Pulmonary tuberculosis and C-reactive protein increased

Summary:

C-reactive protein increased is found among people with Pulmonary tuberculosis, especially for people who are female, 60+ old.

The study analyzes which people have C-reactive protein increased with Pulmonary tuberculosis. It is created by eHealthMe based on reports of 19 people who have Pulmonary tuberculosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary tuberculosis?

Pulmonary tuberculosis (lungs tuberculosis) is found to be associated with 340 drugs and 1,027 conditions by eHealthMe. Check the latest studies of Pulmonary tuberculosis.

What is C-reactive protein increased?

C-reactive protein increased is found to be associated with 1,569 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.

On Aug, 06, 2026

19 people who have Pulmonary Tuberculosis and C-Reactive Protein Increased are studied.

Would you have C-reactive protein increased when you have Pulmonary tuberculosis?

Gender of people who have Pulmonary Tuberculosis and experienced C-Reactive Protein Increased *:

female: 52.63 %
male: 47.37 %

Age of people who have Pulmonary Tuberculosis and experienced C-Reactive Protein Increased *:

Common co-existing conditions for these people *:

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 10.53%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 10.53%
Peritoneal Tuberculosis: 2 people, 10.53%
Hiv Infection: 2 people, 10.53%
Bone Tuberculosis: 2 people, 10.53%
Tonsil Cancer: 1 person, 5.26%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 5.26%
Pharyngeal Ulceration: 1 person, 5.26%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%

Common drugs taken by these people *:

Isoniazid: 7 people, 36.84%
Pyrazinamide: 4 people, 21.05%
Rifadin: 3 people, 15.79%
Rimactane: 2 people, 10.53%
Ethambutol Hydrochloride: 2 people, 10.53%
Isosorbide Dinitrate: 2 people, 10.53%
Zopiclone: 2 people, 10.53%
Rimifon: 2 people, 10.53%
Ursodeoxycholic Acid: 1 person, 5.26%
Efavirenz: 1 person, 5.26%

Common symptoms for these people *:

Fever: 14 people, 73.68%
Diarrhea: 6 people, 31.58%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 26.32%
Rashes (redness): 4 people, 21.05%
Interstitial Lung Disease: 4 people, 21.05%
Red Blood Cell Sedimentation Rate Increased: 4 people, 21.05%
Pleural Effusion (water on the lungs): 4 people, 21.05%
Alanine Aminotransferase Increased: 4 people, 21.05%
Paradoxical Drug Reaction: 3 people, 15.79%
Computerised Tomogram Abnormal: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have C-reactive protein increased?

- Check whether C-reactive protein increased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on C-reactive protein increased and Pulmonary tuberculosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.